The Canadian Cardiovascular Society Dyslipidemia Guidelines help Canadian physicians to diagnose and treat dyslipidemia (high lipid count) in patients and thereby help prevent cardiovascular disease. Below you will find a link to the CCS guidelines as well as our dyslipidemia guideline knowledge translation tools and resources; including smart phone apps, educational slide decks, pocket guides and more. Watch this page for announcements about educational webinars, workshops and accredited e-learning programs.
The 2012 Dyslipidemia Guideline Update is now published in the Canadian Journal of Cardiology . Many developments have occurred since the publication of the widely-used CCS Dyslipidemia guidelines. The 2012 update presents an updated version of the guidelines, incorporating new recommendations based on recent findings and harmonizing CCS guidelines with those from other Societies. Link to guidelines
Dyslipidemia Guidelines App
The CCS Lipid Guidelines App is based on the 2009 Canadian Cardiovascular Society for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult. This App facilitates the adoption of the CCS Lipid guidelines into daily clinical practice by healthcare professionals.
CCS is pleased to provide three highly engaging videos based on the 2009 Dyslipidemia Guidelines.
These videos address existing educational needs of health care professionals including primary care physicians, nurses and pharmacists as identified by a recent CCS needs assessment. Each video is 8-10 minutes and is designed to improve understanding of the 2009 Dyslipidemia Guidelines and put them into practice. Following each video, viewers will have an opportunity to test their knowledge and evaluate the video content.
Start watching now as a team of multidisciplinary cardiovascular health experts present on the following important topics.
Module 1 – Screening for CVD: The Importance of Family History
Module 2 – Risk Stratification and Treatment Target Selection
Module 3 – Strategies to Achieve Treatment Targets
Please note: You will be prompted to enter your email address and then your first and last name to download/stream the file.
It is Canadian Cardiovascular Society policy that no industry support is accepted for the development of guidelines or position statements.
The CCS accepts third party funding for guideline knowledge translation activities, seeking multiple supporters whenever possible. Support is accepted to offset the development and delivery costs of tools, resources, workshops and webinars. Supporters have no involvement in content development. Dyslipidemia Guideline knowledge translation is currently supported by: Merck, Amgen and Pfizer.